Lyra TherapeuticsLYRA
13F holders, Q1 2026 (March 31)1holders −22
0new positions
20sold out
$0.49avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Lyra Therapeutics Inc. (LYRA) in their 13F filings, down 22 from Q4 2025. 0 opened new positions and 20 sold out. The largest holder was Sabby Management, LLC ($51K).
- Company
- Lyra Therapeutics Inc.
- CUSIP
- 55234L204
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 20 | $208K |
All 13F filers, Q4 2025 → Q1 2026: 138,543 shares sold, net −138,543 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Sabby Management, LLC | 0.97% | Reduce -40.6% | 104,059 | $51K |
"% of holder's portfolio" is LYRA's weight in each manager's 13F, not the share of Lyra Therapeutics Inc. the manager owns.